In 2023, Huadong Medicine completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Huadong Medicine has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Huadong Medicine’s data sources below and access millions more through our Disclosure Search.
In 2023, the total operational greenhouse gas (GHG) emissions of Huadong Medicine amounted to 152,103.45 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Huadong Medicine increased by 40.06%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
In 2023, the total Scope 1 emissions of Huadong Medicine were 14,288.85 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2022), Huadong Medicine's Scope 1 emissions increased by 26.39%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
In 2023, Huadong Medicine reported Scope 2 greenhouse gas (GHG) emissions of 137,814.6 tCO₂e without specifying the calculation method. a
Compared to the previous year (2022), Huadong Medicine's Scope 2 emissions (Unspecified Calculation Method) rose by 41.65% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
In 2023, Huadong Medicine reported its Scope 2 emissions using an unspecified methodology. a
In 2023, Huadong Medicine reported Scope 1 greenhouse gas (GHG) emissions of 14,288.85 tCO₂e and total revenues of USD 5,716 millions. This translates into an emissions intensity of 2.5 tCO₂e per millions USD. a
In 2023, Huadong Medicine reported a Scope 1 emissions intensity of 2.5 tCO₂e per millions USD. Compared to the peer group median of 25.27 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
In 2023, Huadong Medicine ranked 2 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Huadong Medicine among the top performers, with one of the lowest emissions intensities relative to peers. a